These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1009 related items for PubMed ID: 25958767

  • 1. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S, Tröltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C.
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS, Lo JC.
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Hasegawa T, Kawakita A, Ueda N, Funahara R, Tachibana A, Kobayashi M, Kondou E, Takeda D, Kojima Y, Sato S, Yanamoto S, Komatsubara H, Umeda M, Kirita T, Kurita H, Shibuya Y, Komori T, Japanese Study Group of Cooperative Dentistry with Medicine (JCDM).
    Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
    Yuh DY, Chang TH, Huang RY, Chien WC, Lin FG, Fu E.
    J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
    [Abstract] [Full Text] [Related]

  • 8. The observational study of delayed wound healing after tooth extraction in patients receiving oral bisphosphonate therapy.
    Hasegawa T, Ri S, Umeda M, Komatsubara H, Kobayashi M, Shigeta T, Yoshitomi I, Ikeda H, Shibuya Y, Asahina I, Komori T.
    J Craniomaxillofac Surg; 2013 Oct; 41(7):558-63. PubMed ID: 23332469
    [Abstract] [Full Text] [Related]

  • 9. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
    Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J.
    J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
    Utreja A, Almas K, Javed F.
    Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
    [Abstract] [Full Text] [Related]

  • 13. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G, Manfredi M, Giovannacci I, Mergoni G, Sarraj A, Mureddu M, Giunta G, Bonanini M, Meleti M, Vescovi P.
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [Abstract] [Full Text] [Related]

  • 14. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER, Basile JD.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [Abstract] [Full Text] [Related]

  • 15. Primary wound closure and perioperative antibiotic therapy for prevention of bisphosphonate-related osteonecrosis of the jaw after tooth extraction.
    Spanou A, Nelson K, Ermer MA, Steybe D, Poxleitner P, Voss PJ.
    Quintessence Int; 2020 May; 51(3):220-228. PubMed ID: 32020132
    [Abstract] [Full Text] [Related]

  • 16. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction.
    Saia G, Blandamura S, Bettini G, Tronchet A, Totola A, Bedogni G, Ferronato G, Nocini PF, Bedogni A.
    J Oral Maxillofac Surg; 2010 Apr; 68(4):797-804. PubMed ID: 20307765
    [Abstract] [Full Text] [Related]

  • 17. Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study.
    Cuozzo A, Iorio-Siciliano V, Vaia E, Mauriello L, Blasi A, Ramaglia L.
    J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):616-621. PubMed ID: 35609780
    [Abstract] [Full Text] [Related]

  • 18. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, Martin D, Liberty D, Lo JC.
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [Abstract] [Full Text] [Related]

  • 19. Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series.
    Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A.
    J Oral Maxillofac Surg; 2010 Jan; 68(1):107-10. PubMed ID: 20006163
    [Abstract] [Full Text] [Related]

  • 20. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.